Net profit of Solara Active Pharma Sciences reported to Rs 8.01 crore in the quarter ended September 2024 as against net loss of Rs 17.16 crore during the previous quarter ended September 2023. Sales declined 18.41% to Rs 346.95 crore in the quarter ended September 2024 as against Rs 425.24 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales346.95425.24 -18 OPM %17.678.85 - PBDT33.3514.37 132 PBT8.01-11.84 LP NP8.01-17.16 LP Powered by Capital Market - Live News

Solara Active Pharma Sciences has allotted 49,000 equity shares under ESOP on 21 October 2024. Powered by Capital Market - Live News

Solara Active Pharma Sciences will hold a meeting of the Board of Directors of the Company on 21 October 2024.Powered by Capital Market - Live News

Solara Active Pharma Sciences announced that the Annual General Meeting (AGM) of the company will be held on 20 September 2024.Powered by Capital Market - Live News

Net Loss of Solara Active Pharma Sciences reported to Rs 13.46 crore in the quarter ended June 2024 as against net loss of Rs 19.55 crore during the previous quarter ended June 2023. Sales rose 3.17% to Rs 363.49 crore in the quarter ended June 2024 as against Rs 352.31 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales363.49352.31 3 OPM %11.535.43 - PBDT11.61-3.45 LP PBT-13.46-29.36 54 NP-13.46-19.55 31 Powered by Capital Market - Live News